Comparison of Different Spectral Domain Optical Coherence Tomography Scanning Areas for Glaucoma Diagnosis
Purpose
To evaluate retinal nerve fiber layer (RNFL), optic nerve head (ONH), and macular thickness measurements for glaucoma detection using the RTVue spectral domain optical coherence tomograph.
Design
Diagnostic, case-control study.
Participants
One hundred forty eyes of 106 glaucoma patients and 74 eyes of 40 healthy subjects from the Diagnostic Innovations in Glaucoma Study (DIGS).
Methods
All patients underwent ocular imaging with the commercially available RTVue. Optic nerve head, RNFL thickness, and macular thickness scans were obtained during the same visit. Receiver operating characteristic (ROC) curves and sensitivities at fixed specificities (80% and 95%) were calculated for each parameter.
Main Outcome Measures
Areas under the ROC curves (AUC) and sensitivities at fixed specificities of 80% and 95%.
Results
The AUC for the RNFL parameter with best performance, inferior quadrant thickness, was significantly higher than that of the best-performing ONH parameter, inferior rim area (0.884 vs 0.812, respectively; P = 0.04). There was no difference between ROC curve areas of the best RNFL thickness parameters and the best inner macular thickness measurement, ganglion cell complex root mean square (ROC curve area = 0.870).
Conclusions
The RTVue RNFL and inner retinal macular thickness measurements had good ability to detect eyes with glaucomatous visual field loss and performed significantly better than ONH parameters.
Financial Disclosure(s)
Proprietary or commercial disclosure may be found after the references.
To access this article, please choose from the options below
Manuscript no. 2009-1274.
Financial Disclosure(s): Linda M. Zangwill – Grant/Financial Support - Heidelberg Engineering, Carl Zeiss, OptovueRobert N. Weinreb – Consultant, Grant/Financial Support - Optovue, Topcon, Carl Zeiss; Grant/Financial Support - Heidelberg EngineeringPamela A. Sample – Grant/Financial Support - Carl Zeiss, Heidelberg Engineering, Welch AllynFelipe A. Medeiros – Consultant, Grant/Financial Support - Carl Zeiss; Lecture Fees - Heidelberg Engineering
Supported in part by NEI EY08208 (PAS), NEI EY11008 (LMZ), Participant retention incentive grants in the form of glaucoma medication at no cost (Alcon Laboratories Inc., Allergan, Pfizer Inc., SANTEN Inc.).
PII: S0161-6420(10)00060-6
doi:10.1016/j.ophtha.2010.01.031
© 2010 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.

